Skip to main content

Table 1 Key R&D, publication, patenting, and pharmaceutical market indicators for China, India, Brazil, South Africa and select developed markets

From: Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators

Country

R&D Expenditure as a % of GDP1

Gross Expenditure on R&D in Billions USD1

Share of Global Scientific Publications

[Annual Growth Rate b/w 2000–2008]2

Annual Growth Rate in Patenting (2000–2006)2

Pharmaceutical Market Size, Billions USD, 2010 (Projected Size in 2015)3

CAGR for Pharmaceutical Market, 2006–2010 (2010–2015 Forecast)3

China

1.5 (2008)

102

12%, [23.4%]

26.5%

25.7 (48.8)

17.3% (13.6%)

India

0.80

24.8

2.3%, [4.7%]**

42%*

14.1 (30.4)

16.6% (16.6%)

Brazil

1.10

20.3

1.6%, [12.2%]***

N/A

15.3 (34.4)

13.1% (17.6%)

Canada

1.84 (2008)

24.0

2.7%

3.9%

26.6 (30.2)

5.4% (2.6%)

Germany

2.54

72.2

4%08

5.7%

37.9 (41.5)

3.4% (1.8%)

Japan

3.44

148

4.8%

4.5%

72.4 (102.7)

4.4% (7.2%) ****

United States

2.82 (2008)

398

16%

2.6%

292.8 (344.7)

2.9% (3.3%)

  1. Sources: 1 UNESCO Science Report 2010. Data is for 2007 unless stated otherwise.
  2. 2 OECD Science, Technology and Industry Outlook 2010. Share of publications is for 2008, except for India where this share represents 2006 Data.
  3. 3 DataMonitor 2010, Country-specific Pharmaceutical Industry Profile Reports.
  4. * Estimate for India is for period 1997–2004.
  5. ** Estimate for India is for 1995–2005.
  6. *** Estimate for Brazil is for 1998–2008.
  7. **** Data for 2005–2009 and 2009–1014.
  8. CAGR stands for Cumulative Annual Growth Rate.
Back to article page

Health Research Policy and Systems

ISSN: 1478-4505

Contact us